MOOD AND ANXIETY DISORDERS PROGRAM (MAP) AT MOUNT SINAI

James Murrough, M.D.

Mood And Anxiety Disorders Program (MAP)

In the News: Dr. Brian Iacoviello Publishes Award-Winning Research

The Academy for Psychosomatic Medicine awarded Dr. Iacoviello the Best Article for Original

Research in 2015 Award. The publication reflects Dr. Iacoviello’s research on factors associated

with positive outcomes (resilience) among live organ donors. The article reflects the

development of a novel assessment tool that allows for more accurate screening of potential live

organ donors. Please join us in congratulating Dr. Iacoviello and his colleagues for winning this

prestigious award.

Recent Publications • Lener MS, Kundu P, Wong E, Dewilde KE, Tang CY, Balchandani P, Murrough JW. (2016).

Cortical abnormalities and association with symptom dimensions across the depressive spectrum. Journal of Affective Disorders, 190, 529-536.

• Iacoviello BM, Charney DS (2015). Developing cognitive-emotional training exercies as interventions for mood and anxiety disorders. European Psychiatry, 30, 75-81.

• Murrough JW, Soleimani, L, Dewilde, KE, Collins KA, Lapidus KA, Iacoviello BM, Lener M, Kautz M, Kim J, Stern JB, Price RB, Perez AM, Brallier JW, Rodriguez GJ, Goodman WK, Iosifescu DV, Charney DS. (2015). Ketamine for rapid reduction of suicidal ideation: A randomized controlled trial. Psychological Medicine, 45, 3571-80.

• Iacoviello BM, Shenoy A, Braoude J, Jennings T, Vaidya S, Brouwer J, Haydel B, Arroyo H, Thakur D, Leinwand J, Rudow DL (2015). The Live Donor Assessment Tool: A psychosocial assessment tool for live organ donors. Psychosomatics, 56, 254-61.

• Iosifescu, DV (2015). Maintaining the initial clinical response after ketamine in bipolar and unipolar depression: An important next-step challenge. Journal of Clinical Psychiatry, 76, 738-40.

• Feder A, Parides MK, Murrough JW, Perez AM, Morgan JE, Saxena S, Kirkwoood, K, Aan Het Rot H, Lapidus KAB, Wan L-B, Iosifescu DV, Charney DS. (2014). Efficacy of intravenous ketamine for treatment of chronic posttraumatic stress disorder: A randomized clinical trial. JAMA Psychiatry, 781, 681-88.

Top left: Kate Collins, Nicholas Van Dam, Drew Kiraly, Elizabeth Wade, Jaclyn Schwartz, Ai Morishita, Marin Kautz,

Megan Hoch. Bottom left: Adriana Feder, Dan Iosifescu, James Murrough, Alison Welch, Seharish Moughal, Sara

Costi, Laili Soleimani, Brian Iacoviello

MAP QUARTERLY February 2016

We at the Mood and Anxiety Disorders Program (MAP) in the Icahn School of Medicine at

Mount Sinai want to wish everyone a Happy New Year. The goal of MAP is to understand the

fundamental causes of mood and anxiety disorders, and to discover new and effective

treatments. We are pleased to bring you this inaugural issue of the MAP Quarterly – a newsletter

that will keep our community abreast of Program activities.

Interested in our research? To learn more, please visit:

mssm.edu/map

Want to

Meet the MAP Team

Dr. Brian Iacoviello Publishes Award-Winning

Research

Want to keep up-to-date with MAP?

Follow us on Twitter: @IcahnMAP

Like us on Facebook: @moodandanxiety

Phone: 212-241-6539

Email: MAP@mssm.edu

MEET OUR DIRECTOR

Dr. James Murrough is a psychiatrist and

investigator whose work focuses on the

study and treatment of mood, anxiety, and

stress. Dr. Murrough joined Mount Sinai in

2011 and currently holds a faculty

appointment in Psychiatry and

Neuroscience. As Director of MAP, Dr.

Murrough leads a multi-disciplinary team of

clinicians and scientists who conduct

cutting-edge biological studies and clinical

trials. He has received research support

from the National Institutes of Health, the

Doris Duke Charitable Foundation, and

several other organizations and is an

associate member of the American

College of Neuropsychopharmacology

(ACNP). He has authored more than 50

peer-reviewed articles and book chapters.

Please join us in congratulating Dr.

Murrough on his new role.